BlackRock’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $23.2M | Sell |
|
|||||
|
2025
Q2 | $18.2M | Buy |
|
|||||
|
2025
Q1 | $48.5M | Buy |
|
|||||
|
2024
Q4 | $89.2M | Buy |
|
|||||
|
2024
Q3 | $118M | Buy |
|
|||||
|
2024
Q2 | $133M | Buy |
|
|||||
|
2024
Q1 | $160M | Sell |
|
|||||
|
2023
Q4 | $178M | Buy |
|
|||||
|
2023
Q3 | $105M | Sell |
|
|||||
|
2023
Q2 | $102M | Sell |
|
|||||
|
2023
Q1 | $93.6M | Sell |
|
|||||
|
2022
Q4 | $109M | Buy |
|
|||||
|
2022
Q3 | $71.7M | Buy |
|
|||||
|
2022
Q2 | $55.1M | Buy |
|
|||||
|
2022
Q1 | $52.8M | Sell |
|
|||||
|
2021
Q4 | $72.9M | Buy |
|
|||||
|
2021
Q3 | $96.2M | Buy |
|
|||||
|
2021
Q2 | $140M | Sell |
|
|||||
|
2021
Q1 | $145M | Buy |
|
|||||
|
2020
Q4 | $163M | Buy |
|
|||||
|
2020
Q3 | $65.7M | Sell |
|
|||||
|
2020
Q2 | $62.4M | Buy |
|
|||||
|
2020
Q1 | $37.7M | Buy |
|
|||||
|
2019
Q4 | $60M | Buy |
|
|||||
|
2019
Q3 | $30.5M | Buy |
|
|||||
|
2019
Q2 | $38.5M | Buy |
|
|||||
|
2019
Q1 | $37.1M | Buy |
|
|||||
|
2018
Q4 | $28.7M | Buy |
|
|||||
|
2018
Q3 | $36.1M | Buy |
|
|||||
|
2018
Q2 | $25.6M | Buy |
|
|||||
|
2018
Q1 | $1.57M | Sell |
|
|||||
|
2017
Q4 | $881K | Buy |
|
|||||
|
2017
Q3 | $595K | Sell |
|
|||||
|
2017
Q2 | $641K | Sell |
|
|||||
|
2017
Q1 | $2.06M | Buy |
|
|||||
|
2016
Q4 | $269K | Sell |
|
|||||
|
2016
Q3 | $773K | Hold |
|
|||||
|
2016
Q2 | $606K | Buy |
|
|||||
|
2016
Q1 | $598K | Hold |
|
|||||
|
2015
Q4 | $916K | Sell |
|
|||||
|
2015
Q3 | $888K | Buy |
|